Daniel J Levangie - Net Worth and Insider Trading

Daniel J Levangie Net Worth

The estimated net worth of Daniel J Levangie is at least $5 Million dollars as of 2024-04-26. Daniel J Levangie is the President, Drug Delivery of Insulet Corp and owns about 22,514 shares of Insulet Corp (PODD) stock worth over $4 Million. Daniel J Levangie is also the Director of Exact Sciences Corp and owns about 22,975 shares of Exact Sciences Corp (EXAS) stock worth over $1 Million. Details can be seen in Daniel J Levangie's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel J Levangie has not made any transactions after 2024-03-01 and currently still holds the listed stock(s).

Transaction Summary of Daniel J Levangie

To

Daniel J Levangie Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel J Levangie owns 4 companies in total, including Exact Sciences Corp (EXAS) , Insulet Corp (PODD) , and Hologic Inc (HOLX) among others .

Click here to see the complete history of Daniel J Levangie’s form 4 insider trades.

Insider Ownership Summary of Daniel J Levangie

Ticker Comapny Transaction Date Type of Owner
EXAS Exact Sciences Corp 2024-03-01 director
PODD Insulet Corp 2016-03-10 director
HOLX Hologic Inc 2007-10-22 director
RNLX Renalytix PLC 2023-07-01 director

Daniel J Levangie Latest Holdings Summary

Daniel J Levangie currently owns a total of 2 stocks. Among these stocks, Daniel J Levangie owns 22,514 shares of Insulet Corp (PODD) as of March 10, 2016, with a value of $4 Million and a weighting of 73.42%. Daniel J Levangie also owns 22,975 shares of Exact Sciences Corp (EXAS) as of March 1, 2024, with a value of $1 Million and a weighting of 26.58%.

Latest Holdings of Daniel J Levangie

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PODD Insulet Corp 2016-03-10 22,514 166.18 3,741,377
EXAS Exact Sciences Corp 2024-03-01 22,975 58.95 1,354,376

Holding Weightings of Daniel J Levangie


Daniel J Levangie Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel J Levangie has made a total of 0 transactions in Insulet Corp (PODD) over the past 5 years. The most-recent trade in Insulet Corp is the sale of 12,299 shares on March 10, 2016, which brought Daniel J Levangie around $379,916.

According to the SEC Form 4 filings, Daniel J Levangie has made a total of 3 transactions in Exact Sciences Corp (EXAS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Exact Sciences Corp is the sale of 5,000 shares on March 1, 2024, which brought Daniel J Levangie around $287,500.

Insider Trading History of Daniel J Levangie

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel J Levangie Trading Performance

GuruFocus tracks the stock performance after each of Daniel J Levangie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel J Levangie is 53.05%. GuruFocus also compares Daniel J Levangie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel J Levangie within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Daniel J Levangie's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Daniel J Levangie

Average Return

63.85%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 13.38 53.05 32.86 63.85 57.87 44.7
Relative Return to S&P 500(%) 14.91 43.76 15.99 56.92 46.4 29.91

Daniel J Levangie Ownership Network

Ownership Network List of Daniel J Levangie

No Data

Ownership Network Relation of Daniel J Levangie


Daniel J Levangie Owned Company Details

What does Exact Sciences Corp do?

Who are the key executives at Exact Sciences Corp?

Daniel J Levangie is the director of Exact Sciences Corp. Other key executives at Exact Sciences Corp include Gen. Mgr. & Precision Oncology Brian Baranick , SVP & Human Resources Sarah Condella , and General Counsel James Herriott .

Exact Sciences Corp (EXAS) Insider Trades Summary

Over the past 18 months, Daniel J Levangie made 1 insider transaction in Exact Sciences Corp (EXAS) with a net sale of 5,000. Other recent insider transactions involving Exact Sciences Corp (EXAS) include a net sale of 36,256 shares made by Sarah Condella , a net sale of 7,471 shares made by James Herriott , and a net sale of 80,189 shares made by Kevin T Conroy .

In summary, during the past 3 months, insiders sold 101,681 shares of Exact Sciences Corp (EXAS) in total and bought 0 shares, with a net sale of 101,681 shares. During the past 18 months, 240,431 shares of Exact Sciences Corp (EXAS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 240,431 shares.

Exact Sciences Corp (EXAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Exact Sciences Corp Insider Transactions

No Available Data

Daniel J Levangie Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel J Levangie. You might contact Daniel J Levangie via mailing address: 85 Swanson Road, Boxborough Ma 01719.

Discussions on Daniel J Levangie

No discussions yet.